Ocugen (OCGN) Common Equity (2014 - 2026)

Ocugen has reported Common Equity for 13 years, with the latest figure at $5.8 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 63.52% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (down 63.52% YoY), and the FY2025 full-year result was -$12.2 million, down 141.06% from the prior year.
• Common Equity for Q1 2026 stood at $5.8 million, up from -$12.2 million in the prior quarter.
• The five-year high for Common Equity was $125.5 million in Q1 2022, with the low at -$12.2 million in Q4 2025.
• Historically, Common Equity has averaged $43.5 million across 5 years, with a median of $40.6 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity jumped 169.99% — and 2025, when it plunged 141.06%.
• Ocugen's Common Equity stood at $74.0 million in 2022, then plunged by 45.17% to $40.6 million in 2023, then declined by 26.95% to $29.6 million in 2024, then sank by 141.06% to -$12.2 million in 2025, then surged by 147.71% to $5.8 million in 2026.
• The last three Common Equity figures came in at $5.8 million (Q1 2026), -$12.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.